<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Lu Q</submitter><funding>NIDDK NIH HHS</funding><funding>NIH HHS</funding><pagination>eadk2536</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12486176</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>385(6716)</volume><pubmed_abstract>Harnessing the microbiome to benefit human health requires an initial step in determining the identity and function of causative microorganisms that affect specific host physiological functions. We show a functional screen of the bacterial microbiota from mice with low intestinal immunoglobulin A (IgA) levels; we identified a Gram-negative bacterium, proposed as &lt;i>Tomasiella immunophila&lt;/i>, that induces and degrades IgA in the mouse intestine. Mice harboring &lt;i>T. immunophila&lt;/i> are susceptible to infections and show poor mucosal repair. &lt;i>T. immunophila&lt;/i> is auxotrophic for the bacterial cell wall amino sugar N-acetylmuramic acid. It delivers immunoglobulin-degrading proteases into outer membrane vesicles that preferentially degrade rodent antibodies with kappa but not lambda light chains. This work indicates a role for symbionts in immunodeficiency, which might be applicable to human disease.</pubmed_abstract><journal>Science (New York, N.Y.)</journal><pubmed_title>A host-adapted auxotrophic gut symbiont induces mucosal immunodeficiency.</pubmed_title><pmcid>PMC12486176</pmcid><funding_grant_id>F32 DK136180</funding_grant_id><funding_grant_id>S10 OD023436</funding_grant_id><pubmed_authors>Zhou JY</pubmed_authors><pubmed_authors>Stappenbeck TS</pubmed_authors><pubmed_authors>Sangwan N</pubmed_authors><pubmed_authors>Han Y</pubmed_authors><pubmed_authors>Nolan LS</pubmed_authors><pubmed_authors>Hitch TCA</pubmed_authors><pubmed_authors>Karell PE</pubmed_authors><pubmed_authors>Baldridge MT</pubmed_authors><pubmed_authors>Espenschied ST</pubmed_authors><pubmed_authors>Salazar V</pubmed_authors><pubmed_authors>Newhall KP</pubmed_authors><pubmed_authors>Lawrence D</pubmed_authors><pubmed_authors>Dwidar M</pubmed_authors><pubmed_authors>Clavel T</pubmed_authors><pubmed_authors>Lu Q</pubmed_authors></additional><is_claimable>false</is_claimable><name>A host-adapted auxotrophic gut symbiont induces mucosal immunodeficiency.</name><description>Harnessing the microbiome to benefit human health requires an initial step in determining the identity and function of causative microorganisms that affect specific host physiological functions. We show a functional screen of the bacterial microbiota from mice with low intestinal immunoglobulin A (IgA) levels; we identified a Gram-negative bacterium, proposed as &lt;i>Tomasiella immunophila&lt;/i>, that induces and degrades IgA in the mouse intestine. Mice harboring &lt;i>T. immunophila&lt;/i> are susceptible to infections and show poor mucosal repair. &lt;i>T. immunophila&lt;/i> is auxotrophic for the bacterial cell wall amino sugar N-acetylmuramic acid. It delivers immunoglobulin-degrading proteases into outer membrane vesicles that preferentially degrade rodent antibodies with kappa but not lambda light chains. This work indicates a role for symbionts in immunodeficiency, which might be applicable to human disease.</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Sep</publication><modification>2026-06-04T00:36:38.504Z</modification><creation>2026-05-03T03:12:33.69Z</creation></dates><accession>S-EPMC12486176</accession><cross_references><pubmed>39325906</pubmed><doi>10.1126/science.adk2536</doi></cross_references></HashMap>